ArticleOPEN ACCESS

Event-free survival in patients with polycythemia vera treated with ropeginterferon alfa-2b versus best available treatment

Leukemia
DOI: 10.1038/s41375-023-02008-6
75Citations
Citations of this article
40Readers
Mendeley users who have this article in their library.

This article is free to access.

Cite

CITATION STYLE

APA

Gisslinger, H., Klade, C., Georgiev, P., Krochmalczyk, D., Gercheva-Kyuchukova, L., Egyed, M., … Kiladjian, J. J. (2023, October 1). Event-free survival in patients with polycythemia vera treated with ropeginterferon alfa-2b versus best available treatment. Leukemia. Springer Nature. https://doi.org/10.1038/s41375-023-02008-6

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free